Psyence Biomedical Valuation
| PBM Stock | USD 2.50 0.12 4.58% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Psyence Biomedical holds a recent Real Value of $2.52 per share. The prevailing price of the company is $2.5. Our model determines the value of Psyence Biomedical from analyzing the company fundamentals such as Shares Outstanding of 1.02 M, return on equity of -0.74, and Shares Owned By Institutions of 2.80 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Psyence Biomedical's price fluctuation is dangerous at this time. Calculation of the real value of Psyence Biomedical is based on 3 months time horizon. Increasing Psyence Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Psyence stock is determined by what a typical buyer is willing to pay for full or partial control of Psyence Biomedical Ltd. Since Psyence Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Psyence Stock. However, Psyence Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.5 | Real 2.52 | Hype 2.2 | Naive 2.47 |
The intrinsic value of Psyence Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Psyence Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Psyence Biomedical Ltd helps investors to forecast how Psyence stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Psyence Biomedical more accurately as focusing exclusively on Psyence Biomedical's fundamentals will not take into account other important factors: About Psyence Biomedical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Psyence Biomedical Ltd. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Psyence Biomedical based exclusively on its fundamental and basic technical indicators. By analyzing Psyence Biomedical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Psyence Biomedical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Psyence Biomedical. We calculate exposure to Psyence Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Psyence Biomedical's related companies. When determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's future performance. For an informed investment choice regarding Psyence Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Biotechnology sector continue expanding? Could Psyence diversify its offerings? Factors like these will boost the valuation of Psyence Biomedical. Anticipated expansion of Psyence directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Psyence Biomedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Psyence Biomedical's market price often diverges from its book value, the accounting figure shown on Psyence's balance sheet. Smart investors calculate Psyence Biomedical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Psyence Biomedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Psyence Biomedical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Psyence Biomedical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.